Published in CA Cancer J Clin on December 24, 2013
Meal frequency and timing in health and disease. Proc Natl Acad Sci U S A (2014) 1.11
Worldwide variations in artificial skyglow. Sci Rep (2015) 1.04
The aging clock and circadian control of metabolism and genome stability. Front Genet (2015) 0.94
Effects of aging on circadian patterns of gene expression in the human prefrontal cortex. Proc Natl Acad Sci U S A (2015) 0.87
Electric light, particularly at night, disrupts human circadian rhythmicity: is that a problem? Philos Trans R Soc Lond B Biol Sci (2015) 0.85
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors. Oncotarget (2016) 0.83
Artificial light at night: melatonin as a mediator between the environment and epigenome. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget (2016) 0.80
Circadian clocks and breast cancer. Breast Cancer Res (2016) 0.79
Circadian Modulation of 8-Oxoguanine DNA Damage Repair. Sci Rep (2015) 0.78
Peripheral Skin Temperature and Circadian Biological Clock in Shift Nurses after a Day off. Int J Mol Sci (2016) 0.77
Melatonin Suppresses the Growth of Ovarian Cancer Cell Lines (OVCAR-429 and PA-1) and Potentiates the Effect of G1 Arrest by Targeting CDKs. Int J Mol Sci (2016) 0.75
Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Circadian disruption-induced breast cancer - knowns and unknowns. Cell Cycle (2016) 0.75
Risk assessment model for invasive breast cancer in Hong Kong women. Medicine (Baltimore) (2016) 0.75
LINE-1 activity as molecular basis for genomic instability associated with light exposure at night. Mob Genet Elements (2015) 0.75
The aging clock: circadian rhythms and later life. J Clin Invest (2017) 0.75
Carcinogenic effects of circadian disruption: an epigenetic viewpoint. Chin J Cancer (2015) 0.75
Cycles of circadian illuminance are sufficient to entrain and maintain circadian locomotor rhythms in Drosophila. Sci Rep (2016) 0.75
Influence of Chronic Exposure to Simulated Shift Work on Disease and Longevity in Disease-Prone Inbred Mice. Comp Med (2017) 0.75
The "realities" of our modern light-dark cycle. J Clin Sleep Med (2014) 0.75
Sleep characteristics, light at night and breast cancer risk in a prospective cohort. Int J Cancer (2017) 0.75
Shedding light on the role of circadian disruption in breast cancer etiology. Eur J Epidemiol (2016) 0.75
Neurodegeneration and the Circadian Clock. Front Aging Neurosci (2017) 0.75
Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness. Oncol Lett (2017) 0.75
Resources of dark skies in German climatic health resorts. Int J Biometeorol (2016) 0.75
Health consequences of electric lighting practices in the modern world: A report on the National Toxicology Program's workshop on shift work at night, artificial light at night, and circadian disruption. Sci Total Environ (2017) 0.75
Melatonin and Hippo Pathway: Is There Existing Cross-Talk? Int J Mol Sci (2017) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med (2004) 11.17
Phototransduction by retinal ganglion cells that set the circadian clock. Science (2002) 10.42
Extensive and divergent circadian gene expression in liver and heart. Nature (2002) 9.64
Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science (2002) 9.08
Stability, precision, and near-24-hour period of the human circadian pacemaker. Science (1999) 7.74
The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet (2008) 7.65
Reconstitution of circadian oscillation of cyanobacterial KaiC phosphorylation in vitro. Science (2005) 7.28
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell (2002) 6.05
Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature (2005) 5.96
Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature (2003) 5.84
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet (2012) 4.76
Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol (2007) 4.60
Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol (2000) 4.39
Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci (2001) 4.36
Hypothesis: does breast cancer originate in utero? Lancet (1990) 4.22
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol (2007) 4.10
Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol (2009) 4.09
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
Melatonin in humans. N Engl J Med (1997) 3.60
Light suppresses melatonin secretion in humans. Science (1980) 3.45
A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep (2003) 3.31
Sleep duration and breast cancer: a prospective cohort study. Cancer Res (2005) 3.26
Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat (2012) 3.09
Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med (2012) 3.08
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol (2013) 3.02
Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep (2006) 2.94
Entrainment of the human circadian clock to the natural light-dark cycle. Curr Biol (2013) 2.86
Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer (1990) 2.82
Metabolic consequences of sleep and sleep loss. Sleep Med (2008) 2.67
High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab (2003) 2.67
Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology (2005) 2.65
High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab (2004) 2.49
Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol (2010) 2.48
Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol (2009) 2.40
Electric power use and breast cancer: a hypothesis. Am J Epidemiol (1987) 2.31
Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis (2005) 2.31
The influence of light at night exposure on melatonin levels among Canadian rotating shift nurses. Cancer Epidemiol Biomarkers Prev (2011) 2.27
Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med (2013) 2.24
Effects of chronic jet lag on tumor progression in mice. Cancer Res (2004) 2.21
The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res (2002) 2.18
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res (2005) 2.12
Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev (2004) 2.10
Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect (2007) 2.07
Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int (2008) 2.04
Dose-response relationship for light intensity and ocular and electroencephalographic correlates of human alertness. Behav Brain Res (2000) 2.01
Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med (2012) 1.98
Melatonin, sleep disturbance and cancer risk. Sleep Med Rev (2008) 1.96
Electric power, pineal function, and the risk of breast cancer. FASEB J (1992) 1.95
Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A (2013) 1.94
Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol (2001) 1.94
Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions. Trends Neurosci (2011) 1.88
Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev (2009) 1.83
Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology (2002) 1.82
Profound bilateral blindness and the incidence of breast cancer. Epidemiology (1991) 1.81
Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J Natl Cancer Inst (1980) 1.70
Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J Appl Physiol (1985) (2011) 1.68
Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev (2012) 1.67
The evolution of irradiance detection: melanopsin and the non-visual opsins. Philos Trans R Soc Lond B Biol Sci (2009) 1.63
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60
Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine (2005) 1.57
Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. J Pineal Res (2008) 1.56
Photic regulation of melatonin in humans: ocular and neural signal transduction. J Biol Rhythms (1997) 1.55
Mammalian circadian clock and metabolism - the epigenetic link. J Cell Sci (2010) 1.55
Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res (2005) 1.53
Riding tandem: circadian clocks and the cell cycle. Cell (2007) 1.49
Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev (2005) 1.47
Melatonin: a multitasking molecule. Prog Brain Res (2010) 1.46
CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res (2010) 1.45
Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab (2010) 1.43
Invited commentary: validity of case-control studies of sleep duration and breast cancer. Am J Epidemiol (2013) 1.40
Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle (2008) 1.35
Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol (1985) (2002) 1.33
Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat (2012) 1.28
Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control (2010) 1.27
The human circadian system adapts to prior photic history. J Physiol (2011) 1.27
Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer (2011) 1.27
Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control (2001) 1.26
Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res (2011) 1.20
Circadian clock control of the cellular response to DNA damage. FEBS Lett (2010) 1.20
Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol (1985) (2010) 1.20
Effects of light and food schedules on liver and tumor molecular clocks in mice. J Natl Cancer Inst (2005) 1.16
Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res (1999) 1.16
Chronotherapy and the molecular clock: Clinical implications in oncology. Adv Drug Deliv Rev (2010) 1.15
Circadian clock and breast cancer: a molecular link. Cell Cycle (2007) 1.14
Sleep, diurnal preference, health, and psychological well-being: a prospective single-allelic-variation study. Chronobiol Int (2012) 1.13
Development of melanopsin-based irradiance detecting circuitry. Neural Dev (2011) 1.13
Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci (2003) 1.12
Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev (2012) 1.12
Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat (2003) 1.11
Do permanent night workers show circadian adjustment? A review based on the endogenous melatonin rhythm. Chronobiol Int (2008) 1.11
Cell cycle proteins in epithelial cell differentiation: implications for breast cancer. Cell Cycle (2010) 1.10
Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol (2013) 1.10
Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.10
Dose-response relationship between light irradiance and the suppression of plasma melatonin in human volunteers. Brain Res (1988) 1.09
Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst (2013) 1.08
Visual impairment and circadian rhythm disorders. Dialogues Clin Neurosci (2007) 1.07
Human melatonin and alerting response to blue-enriched light depend on a polymorphism in the clock gene PER3. J Clin Endocrinol Metab (2011) 1.06
Adverse health effects of nighttime lighting: comments on American Medical Association policy statement. Am J Prev Med (2013) 1.06
Effect of reducing interns' work hours on serious medical errors in intensive care units. N Engl J Med (2004) 13.16
The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med (2005) 4.98
Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep (2006) 2.94
Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr Biol (2007) 2.68
High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab (2003) 2.67
Sleep disorders, health, and safety in police officers. JAMA (2011) 2.16
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res (2005) 2.12
Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect (2007) 2.07
Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light. Sci Transl Med (2010) 1.70
Mindfulness-based stress reduction lowers psychological distress in medical students. Teach Learn Med (2003) 1.69
Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab (2010) 1.43
The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects. J Sleep Res (2002) 1.41
Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev (2012) 1.35
Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol (1985) (2002) 1.33
Neurobehavioral, health, and safety consequences associated with shift work in safety-sensitive professions. Curr Neurol Neurosci Rep (2009) 1.33
A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psychooncology (2006) 1.27
Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry (2005) 1.27
Melanopsin and rod-cone photoreceptors play different roles in mediating pupillary light responses during exposure to continuous light in humans. J Neurosci (2012) 1.25
Human phase response curve to a 1 h pulse of bright white light. J Physiol (2012) 1.23
Light visor treatment for jet lag after westward travel across six time zones. Aviat Space Environ Med (2002) 1.21
Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol (1985) (2010) 1.20
Effective implementation of work-hour limits and systemic improvements. Jt Comm J Qual Patient Saf (2007) 1.19
Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat (2003) 1.11
The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms (2003) 1.11
Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.10
Human responses to bright light of different durations. J Physiol (2012) 1.08
Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst (2013) 1.08
Dark-phase light contamination disrupts circadian rhythms in plasma measures of endocrine physiology and metabolism in rats. Comp Med (2010) 1.07
Adverse health effects of nighttime lighting: comments on American Medical Association policy statement. Am J Prev Med (2013) 1.06
The physiological period length of the human circadian clock in vivo is directly proportional to period in human fibroblasts. PLoS One (2010) 1.05
Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts. Cancer Res (2011) 1.04
Effects of spectral transmittance through standard laboratory cages on circadian metabolism and physiology in nude rats. J Am Assoc Lab Anim Sci (2013) 1.04
Work at night and breast cancer--report on evidence-based options for preventive actions. Scand J Work Environ Health (2012) 1.04
Dim light adaptation attenuates acute melatonin suppression in humans. J Biol Rhythms (2006) 1.01
Plasma melatonin rhythms in young and older humans during sleep, sleep deprivation, and wake. Sleep (2007) 1.00
Total visual blindness is protective against breast cancer. Cancer Causes Control (2009) 0.98
Integrative medicine research at an academic medical center: patient characteristics and health-related quality-of-life outcomes. J Altern Complement Med (2008) 0.97
Dietary factors and growth and metabolism in experimental tumors. J Nutr Biochem (2007) 0.97
Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J Nutr (2005) 0.96
Ocular input for human melatonin regulation: relevance to breast cancer. Neuro Endocrinol Lett (2002) 0.96
Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia (2011) 0.95
Blue light stimulates cognitive brain activity in visually blind individuals. J Cogn Neurosci (2013) 0.95
Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst (2004) 0.95
Analysis method and experimental conditions affect computed circadian phase from melatonin data. PLoS One (2012) 0.95
Objective and subjective measures of sleepiness, and their associations with on-road driving events in shift workers. J Sleep Res (2012) 0.95
Human phase response curve to a single 6.5 h pulse of short-wavelength light. J Physiol (2012) 0.95
Acute effects of bright light exposure on cortisol levels. J Biol Rhythms (2010) 0.94
Melanopsin, photosensitive ganglion cells, and seasonal affective disorder. Neurosci Biobehav Rev (2012) 0.91
Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β. Mol Endocrinol (2012) 0.90
Chronobiology of epilepsy: diagnostic and therapeutic implications of chrono-epileptology. J Clin Neurophysiol (2011) 0.90
Learning to live on a Mars day: fatigue countermeasures during the Phoenix Mars Lander mission. Sleep (2012) 0.90
Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action. J Pineal Res (2013) 0.89
Timed melatonin treatment for delayed sleep phase syndrome: the importance of knowing circadian phase. Sleep (2005) 0.89
High-intensity red light suppresses melatonin. Chronobiol Int (2006) 0.87
Light during darkness, melatonin suppression and cancer progression. Neuro Endocrinol Lett (2002) 0.87
Timing of sleep and its relationship with the endogenous melatonin rhythm. Front Neurol (2010) 0.87
Eliminating animal facility light-at-night contamination and its effect on circadian regulation of rodent physiology, tumor growth, and metabolism: a challenge in the relocation of a cancer research laboratory. J Am Assoc Lab Anim Sci (2011) 0.86
Evaluation of a single-channel nasal pressure device to assess obstructive sleep apnea risk in laboratory and home environments. J Clin Sleep Med (2013) 0.86
Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Integr Cancer Ther (2009) 0.85
Light during darkness and cancer: relationships in circadian photoreception and tumor biology. Cancer Causes Control (2006) 0.84
Photoreception for circadian, neuroendocrine, and neurobehavioral regulation. J Physiol Anthropol (2007) 0.83
Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth. Curr Aging Sci (2013) 0.83
Deterioration of neurobehavioral performance in resident physicians during repeated exposure to extended duration work shifts. Sleep (2012) 0.82
Does simulator-based clinical performance correlate with actual hospital behavior? The effect of extended work hours on patient care provided by medical interns. Acad Med (2010) 0.82
Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin. Breast Cancer Res Treat (2010) 0.82
Validation of a light questionnaire with real-life photopic illuminance measurements: the Harvard Light Exposure Assessment questionnaire. Cancer Epidemiol Biomarkers Prev (2011) 0.81
Randomized controlled trial of light therapy for fatigue following traumatic brain injury. Neurorehabil Neural Repair (2013) 0.80
Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells. J Pineal Res (2014) 0.80
Physiologic melatonin concentration, omega-3 fatty acids, and conjugated linoleic acid inhibit fatty acid transport in rodent hind limb skeletal muscle in vivo. Comp Med (2003) 0.79
Improved neurobehavioral performance during the wake maintenance zone. J Clin Sleep Med (2013) 0.79
Conjugated linoleic acid isomers and trans fatty acids inhibit fatty acid transport in hepatoma 7288CTC and inguinal fat pads in Buffalo rats. J Nutr (2004) 0.79
Differential inhibition of fatty acid transport in tissue-isolated steroid receptor negative human breast cancer xenografts perfused in situ with isomers of conjugated linoleic acid. Cancer Lett (2004) 0.79
Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents. J Am Assoc Lab Anim Sci (2006) 0.79
Circadian clock genes and risk of fatal prostate cancer. Cancer Causes Control (2014) 0.79
Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5. J Pineal Res (2012) 0.79
Cappuccio response to correspondence. QJM (2009) 0.78
Associations between number of consecutive night shifts and impairment of neurobehavioral performance during a subsequent simulated night shift. Scand J Work Environ Health (2016) 0.78
Temporal dynamics of ocular indicators of sleepiness across sleep restriction. J Biol Rhythms (2013) 0.78
A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats. Comp Med (2012) 0.78
Inferior retinal light exposure is more effective than superior retinal exposure in suppressing melatonin in humans. J Biol Rhythms (2003) 0.77
Safety considerations for the use of blue-light blocking glasses in shift-workers. J Pineal Res (2007) 0.77
Prevalence of Circadian Misalignment and Its Association with Depressive Symptoms in Delayed Sleep Phase Disorder. Sleep (2016) 0.77
Toward optimizing lighting as a countermeasure to sleep and circadian disruption in space flight. Acta Astronaut (2005) 0.76
Dietary fish oil deactivates a growth-promoting signaling pathway in hepatoma 7288CTC in Buffalo rats. Nutr Cancer (2006) 0.76
Classifying performance impairment in response to sleep loss using pattern recognition algorithms on single session testing. Accid Anal Prev (2012) 0.75